<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pharmacological blockade of peripheral and brain <z:chebi fb="0" ids="2719,48432">Angiotensin II</z:chebi> (<z:chebi fb="0" ids="48432">Ang II</z:chebi>) AT(1) receptors protects against <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To clarify the protective role of brain AT(1) receptors, we examined the effects of specific antisense oligodeoxynucleotides (AS-ODN) targeted to AT(1) receptor <z:chebi fb="2" ids="33699">mRNA</z:chebi> administered intracisternally to spontaneously hypertensive rats (SHRs), 4 and 7 days before middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion, and we determined the <z:mpath ids='MPATH_124'>infarct</z:mpath> size and tissue swelling 24 h after surgery </plain></SENT>
<SENT sid="2" pm="."><plain>A single intracisternal injection of AT(1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> receptor antisense oligodeoxynucleotides reduced systemic blood pressure for 5 days and AT(1) receptor binding for at least 4 days in the area postrema and the nucleus of the solitary tract </plain></SENT>
<SENT sid="3" pm="."><plain>A similar injection of scrambled oligodeoxynucleotides (SC-ODN) was without effect </plain></SENT>
<SENT sid="4" pm="."><plain>Both blood pressure and AT(1) receptor binding returned to <z:mpath ids='MPATH_458'>normal</z:mpath> 7 days after antisense receptor <z:chebi fb="2" ids="33699">mRNA</z:chebi> administration </plain></SENT>
<SENT sid="5" pm="."><plain>Both the infarction size and the tissue swelling after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> were reduced when the antisense oligodeoxynucleotide was administered 7 days, but not 4 days, before the operation </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that 4 to 5 days of decrease in brain AT(1) receptor binding by a single administration of an AT(1) receptor <z:chebi fb="2" ids="33699">mRNA</z:chebi> oligodeoxynucleotide are sufficient to significantly protect the brain against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> resulting from total occlusion of a major cerebral vessel </plain></SENT>
</text></document>